A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and determining their health care-associated transmission, researchers found.

The local gene-sequencing company and a U.S. clothing company face sales restrictions in China as part of that country’s ...

On Monday, for the second time in as many business days, Illumina (NASDAQ: ILMN) stock took it on the chin because of an ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

Fintel reports that on February 10, 2025, Barclays downgraded their outlook for Illumina (NasdaqGS:ILMN) from Equal-Weight to ...

We recently published an article titled These 10 Companies Led Monday’s Downturn. In this article, we are going to take a ...

The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.